Breaking Research May Help To Uncover Effective Cancer Treatment For Pets And People

Spread the Word
Listed Under

* Cancer
* Research
* Veterinary
* Medical Oncology
* Pets

* Medical
* Pets

* Grand Rapids - Michigan - US

GRAND RAPIDS, Mich. - Jan. 18, 2014 - PRLog -- Animal Cancer Foundation’s 2010 Comparative Oncology Grant recipients Nicholas S. Duesbery, PhD , head of Van Andel Research Institute’s Laboratory of Cancer and Developmental Biology, Barbara E. Kitchell, DVM, PhD, DACVIM, Michigan State University & Van Andel Research Institute, and Nicholas Andersen, postdoctoral fellow at Van Andel Institute, have recently uncovered evidence that a targeted chemotherapeutic agent is effective on a common, aggressive form of cancer in dogs, hemangiosarcoma, a canine cancer which has also been shown to be an effective model for human angiosarcoma.

Van Andel Research Institute conducts biomedical research, with a focus on cancer and with an emphasis on translating scientific research results into clinical applications. The three research doctors, specializing in human and animal medicine, have published their research in the AACR journal Molecular Cancer Therapeutics, Pharmacologic Inhibition of MEK Signaling Prevents Growth of Canine Hemangiosarcoma.

Animal Cancer Foundation is proud to be a part of this historic discovery.  The ACF grant to Doctors Duesbery, Kitchell,and Andersen allowed for the purchase of theEppendorf EP Motion Automated Liquid Handling platform.  According to Dr. Duesbery, “use of this automated system greatly accelerated our pace of discovery.”

The research team is now engaged in a follow-up study that will allow them to combine the growth inhibitor with other drugs that show synergy in combating this cancer.

Animal Cancer Foundation’s grant to Dr. Duesbery was made in honor of WPLJ-FM’s morning radio personality Scott Shannon and his wife Trish Shannon to recognize their commitment to comparative oncology research.   The grant memorializes the Shannon’s beloved Golden Retriever Jimmy, ACF’s Animal Ambassador, who thrived for two years after treatment for bone cancer.

Media Contact
Barbara Cohen
Source:Van Andel Research Institute
Email:*** Email Verified
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse

Like PRLog?
Click to Share